Prof. Frank Leebeek: About 20 % of People with Von Willebrand’s Disease Have Something Strange Going On
Erasmus MC shared a post on LinkedIn:
“Scientists at Erasmus MC have discovered that Von Willebrand’s blood clotting disease is not always caused by an error in the gene of the same name. A problem in the secretion of the clotting protein can also trigger the disease, they showed.
In people with Von Willebrand disease, something goes wrong in blood clotting. This is usually because their body produces too little or a poorly functioning version of the clotting protein Von Willebrand factor. That protein acts as a kind of band-aid to stop bleeding.
About twenty percent of people with Von Willebrand’s disease have something strange going on. They do not have an error in the Von Willebrand factor gene, but they do have too little clotting protein in their blood. “We have been looking for years to find out what causes the disease in these people,” says hematologist Prof. Frank Leebeek of Erasmus MC. A recent study by the Department of Hematology, published in Blood, points to a new cause.”
Read full paper here.
Stay updated with Hemostasis Today.
-
May 23, 2026, 08:15Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
-
May 23, 2026, 07:59Toward a Dedicated Framework for MIg-Driven Hemostatic Disorders – JTH
-
May 23, 2026, 07:53Ankit Panthari: Can Haemophilia Serve as A Health System Model for Other Rare Diseases in India?
-
May 23, 2026, 07:43Ted Roh: Indonesia’s Plasma Fractionation Plant Wins Social Infrastructure Deal of the Year at the IJGlobal Awards 2025
-
May 23, 2026, 07:36Angie Read: Stories of Strength and Resilience on The Latest Episode of Stroke Sisters
-
May 23, 2026, 07:30Ozlem Fidanci: Reflections From WHA79 on the Future of Stroke Care
-
May 23, 2026, 07:21Ney Carter Borges: Where the Benefit Appears in Dual Antiplatelet Therapy
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia